Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 123710
Published online Aug 15, 2026. doi: 10.4251/wjgo.123710
Published online Aug 15, 2026. doi: 10.4251/wjgo.123710
Table 1 Clinicopathological data of hepatocellular carcinoma patients (n = 102)
| Clinicopathological index | Number of patients | % | |
| Sex | Male | 54 | 52.94 |
| Female | 48 | 47.06 | |
| Age (years) | < 60 | 67 | 65.69 |
| > 60 | 35 | 34.31 | |
| Hepatitis B/C surface antigen | Positive | 68 | 66.67 |
| Negative | 34 | 33.33 | |
| Liver cirrhosis | Yes | 79 | 77.45 |
| No | 23 | 22.55 | |
| Liver function classification | Child-Pugh A | 74 | 72.55 |
| Child-Pugh B | 28 | 27.45 | |
| Tumor size (cm) | > 5 | 41 | 40.20 |
| < 5 | 61 | 59.80 | |
| Tumor number | Single | 84 | 82.35 |
| Multiple | 18 | 17.65 | |
| AFP level (ng/mL) | > 400 | 64 | 62.75 |
| < 400 | 38 | 37.25 | |
| Vascular invasion | Yes | 39 | 38.24 |
| No | 63 | 61.76 | |
| Cancer embolism | Yes | 38 | 37.25 |
| No | 64 | 62.75 | |
| Pathological grade | I/II | 59 | 57.84 |
| III/IV | 43 | 42.16 | |
| TNM staging | I | 61 | 59.80 |
| II/III | 41 | 40.20 | |
Table 2 Relationship between tensin 4 protein expression and clinicopathological features in hepatocellular carcinoma, n (%)
| Clinicopathological feature | n | Negative expression | Positive expression | P value | |
| Sex | Male | 54 | 12 (22.22) | 42 (77.78) | 0.569 |
| Female | 48 | 13 (27.08) | 35 (72.92) | ||
| Age (years) | < 60 | 67 | 17 (25.37) | 50 (74.63) | 0.779 |
| > 60 | 35 | 8 (21.05) | 27 (78.95) | ||
| Hepatitis B/C surface antigen | Positive | 68 | 19 (27.94) | 49 (72.06) | 0.255 |
| Negative | 34 | 6 (17.65) | 28 (82.35) | ||
| Liver cirrhosis | Yes | 79 | 18 (22.78) | 61 (77.22) | 0.453 |
| No | 23 | 7 (30.43) | 16 (69.57) | ||
| Liver function classification | Child-Pugh A | 74 | 15 (20.27) | 59 (79.73) | 0.106 |
| Child-Pugh B | 28 | 10 (35.71) | 18 (64.29) | ||
| Tumor size, cm | > 5 | 41 | 11 (26.83) | 30 (73.17) | 0.655 |
| < 5 | 61 | 14 (22.95) | 47 (77.05) | ||
| Tumor number | Single | 84 | 18 (21.43) | 66 (78.57) | 0.118 |
| Multiple | 18 | 7 (38.89) | 11 (61.11) | ||
| AFP level (ng/mL) | > 400 | 64 | 13 (20.31) | 51 (79.69) | 0.201 |
| < 400 | 38 | 12 (31.58) | 26 (68.42) | ||
| Vascular invasion | Yes | 39 | 5 (12.82) | 34 (87.18) | 0.031 |
| No | 63 | 20 (31.75) | 43 (68.25) | ||
| Cancer embolism | Yes | 38 | 5 (13.16) | 33 (86.84) | 0.04 |
| No | 64 | 20 (31.25) | 44 (68.75) | ||
| Pathological grade | I/II | 59 | 19 (32.20) | 40 (67.80) | 0.034 |
| III/IV | 43 | 6 (13.95) | 37 (86.05) | ||
| TNM staging | I | 61 | 17 (27.87) | 44 (72.13) | 0.336 |
| II/III | 41 | 8 (19.51) | 33 (80.49) | ||
- Citation: Chen GL, Liu JH. Expression of tensin 4 in hepatocellular carcinoma and its role in epithelial-mesenchymal transformation. World J Gastrointest Oncol 2026; 18(8): 123710
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/123710.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123710